Reliable detection of microplastics by surface-enhanced Raman scattering (SERS) is often hindered by poor particle–substrate contact and limited access to plasmonic hotspots on conventional planar substrates optimized for molecular adsorption. Here, we report a rapid microwave-assisted carbothermal shock strategy to fabricate silver nanoparticle-decorated electrospun carbon fibers (AgNPs@ECF) as a three-dimensional plasmonic platform tailored for solid microplastic sensing. Localized microwave-induced heating in a mixed ethanol–hexane system enables Ag nanoparticle nucleation and anchoring on conductive carbon fibers within 45 s, yielding a mechanically compliant, junction-rich architecture without chemical reductants or vacuum processing. The AgNPs@ECF composite was evaluated using morphologically weathered polystyrene (PS) and polyethylene terephthalate (PET) microplastics, along with size-controlled PS bead standards ranging from ~50 nm to 45 μm. Across these models, SERS response is governed primarily by particle–substrate contact geometry and near-field accessibility rather than polymer type. The strongest enhancement occurs in the sub-micrometer regime, where particles can engage multiple AgNP-decorated fiber junctions, while ultrasmall and large, smooth particles show reduced enhancement due to limited contact or rapid field decay. Spatially resolved Raman mapping and finite-difference time-domain simulations support a contact-dominated enhancement mechanism, revealing localized field confinement at particle–fiber interfaces. These results establish the design principles for three-dimensional SERS substrates targeting heterogeneous solid particulates, demonstrating that contact-accessible plasmonic architectures are critical for reliable microplastic detection under realistic solid-particle measurement conditions.

We demonstrate helicity preserving engineered chiral light on a tunable achiral nanostructured SEIRA-VCD platform that can enable precise detection and classification of diverse chiral compounds, reshaping drug design and biomolecular applications.

We demonstrate a biosensing platform featuring a plasmonic “aptasensor”, that can perform rapid, sensitive, and selective detection of the neurotransmitter dopamine in various biological fluids including whole blood, potentially revolutionizing medical diagnostics and disease monitoring.